Belize vs Tunisia: Cause of death, by non-communicable diseases, female
Belize
66.6%
in 2021
Tunisia
65.4%
in 2021
Belize rank
103rd
Tunisia rank
106th
Cause of death, by non-communicable diseases, female over time
- Belize
- Tunisia
How they compare
Belize currently reports 66.6% against 65.4% in Tunisia, a difference of 1.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Tunisia ahead.
Belize ranks 103rd and Tunisia ranks 106th of 185 countries.
Tunisia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 67.9% | 78.5% | 10.7% | Tunisia |
| 2010s | 73.2% | 86.8% | 13.6% | Tunisia |
| 2020s | 69.9% | 75.2% | 5.3% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Belize or Tunisia?
- Belize, at 66.6% against 65.4% in Tunisia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Belize and Tunisia?
- 1.2%, with Belize ahead.
- How many years of comparable data are there for Belize and Tunisia?
- 6 years are reported by both, from 2000 to 2021.
- How do Belize and Tunisia rank globally for cause of death, by non-communicable diseases, female?
- Belize ranks 103rd and Tunisia ranks 106th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.